Real-Time Myocardial Perfusion Echocardiography in the ICU

Completed · Phase 4

Conditions studied: Myocardial Perfusion Imaging

In brief

This study is being done to find out if and how much the use of RTMPE improves a provider's confidence in the diagnosis they assign. This is important because the use of RTMPE may decrease the need for any additional invasive testing.

Key facts

Study ID

NCT03173716

Run by

Mayo Clinic

People needed

24

Starts

2017-09-28

Expected to finish

2019-12-31

Last updated by the study team

2020-09-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults age ≥ 18 years
• Located in a designated ICU
• TTE ordered by the primary care team
• Significant delta in troponin trend
• Concern for myocardial ischemia
• Women of child-bearing potential must have a clinical negative pregnancy test result
• Experienced sonographer available to complete RTMPE portion of the exam
• Provider willing to complete the study survey

You may not qualify if…

• Adults < 18 years
• Contraindication to echo contrast administration
• Location other than an ICU
• No significant delta in troponin trend

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.